Analyzing ATNF’s current quarter earnings projections

180 Life Sciences Corp (ATNF)’s stock has witnessed a price hike of 26.70% from the previous close with its current price standing at $2.37. Its current price is -86.65% under its 52-week high of $17.75 and 104.26% more than its 52-week low of $1.16. Based on the past 30-day period, the stock price is -15.68% below the high and +38.46% above the low.

The 200-day Simple moving average is often placed more emphasis on by traders because of daily price changes. Investors will use the SMA-200 in different situations in trading activity as a key indicator to determine their support and resistance levels, and at the moment, ATNF’s SMA-200 is $2.1926.

ATNF’s price to book ratio for the most recent quarter was 0.65, resulting in an 24.67 price to cash per share for the period.

How does 180 Life Sciences Corp (ATNF) stock rate among analysts? Buy, sell, or hold?

The key to trading is to concentrate on the future rather than on the past. During uncertain times, it can be hard to make decisions. The analysts who understand how a market works are usually the most accurate at forecasting its future. Currently, there are 0 brokerage firms that recommend the stock as a Strong Sell. The ratings are commonly aggregated into a single number between 1 and 5. Buy or strong buy is scored 5, outperform is scored 4, hold is scored 3, underperform is scored 2 and strong sell is 1. Using a scale of 1-5, the current average recommendation is 0.00 in simple terms.

180 Life Sciences Corp (NASDAQ: ATNF) Ownership Details

I will give a breakdown of the key shareholders in 180 Life Sciences Corp (ATNF). Recent figures show that the company’s insiders hold 4.34% of shares. A total of 7 institutional investors hold shares in the company, making 3.45% of its stock and 3.61% of its float.

Sep 30, 2024, it was reported that the Company’s largest institutional holder is Virtu Financial LLC holding total of 14.09 shares that make 0.71% of the company’s total number of shares and are currently priced at 32261.0.

The securities firm UBS Group AG holds 6.85 shares of ATNF, making it the second largest institutional shareholder. Taking this into account, the holding percentage comes to 0.35%, and the holding percentage of shares is valued at 15679.0.

An overview of 180 Life Sciences Corp’s technicals

In order to learn about trade movements and investor behavior, it is best to analyze the short, medium, and long term technical indicators along with the average volume of a stock. A 20-day average of the stock’s daily volume suggests 180 Life Sciences Corp (ATNF) traded 717,023 shares per day, with a moving average of $2.0715 and price change of +0.1000. With the moving average of $2.8928 and a price change of +0.9600, about 2,790,897 shares changed hands on average over the past 50 days. Finally, ATNF’s 100-day average volume is 1,423,313 shares, alongside a moving average of $2.3326 and a price change of +0.4750.

Related Posts